Lung Cancer (E6508): A phase II study of L-BLP25 and bevacizumab in unresectable stage IIIA and IIIB non-squamous non-small cell lung cancer after definitive chemoradiation (2_PRO00000270)

Advanced Non-small Cell Lung Cancer (SWOG-S0819): A randomized, phase III study comparing carboplatin/paclitaxel or arboplatin/paclitaxel/bevacizumab with or without concurrent cetuximab in patients with advanced non-small cell lung cancer (NSCLC) (2_PRO00000696

Previously Untreated unresectable or metastatic melanoma: BMS 209-067: A Phase 3, Randomized, Double-Blind Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab Versus Ipilimumab Monotherapy in Subjects with Previously Untreated

Gynecologic Tissue: The Lehigh Valley Health Network Gynecologic Oncology Tissue Project (1_PRO00000035)

Melanoma (ECOG #E1609): A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma (2_PRO00000797 - CIRB)

Endometrial Cancer (GOG #0258): A randomized phase III trial of cisplatin and tumor volume directed irradiation followed by carboplatin and paclitaxel versus carboplatin and paclitaxel for optimally debulked, advanced endometrial

Cancer with Bone Metastases (SWOG S0702): A prospective observational multicenter cohort study to assess the incidence of osteonecrosis of the jaw (ONJ) in cancer patients with bone metastases starting zoledronic

Wilms Tumor (COG #AREN0534): Treatment for Patients with Bilateral, Multicentric, or Bilaterally-Predisposed Unilateral Wilms Tumor: A Group-wide Phase III Study (1_PRO00000569 - CIRB)

ABTR01B1: Children's Oncology Group protocol for collecting and banking pediatric research specimens including rare pediatric tumors

 

Urinary Tract Cancer (CALGB-90601): A randomized double-blinded phase III study comparing gemcitabine, cisplatin, and bevacizumab to gemcitabine, cisplatin, and placebo in patients with advanced transitional cell carcinoma, NCI supplies agent(s)